Literature DB >> 21115499

Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins.

Alessandra Bertoni1, Paola Giuliano, Mario Galgani, Deborah Rotoli, Luca Ulianich, Annagrazia Adornetto, Maria Rosaria Santillo, Antonio Porcellini, Vittorio Enrico Avvedimento.   

Abstract

To find a common pathogenetic trait induced by polyQ-expanded proteins, we have used a conditional expression system in PC12 cells to tune the expression of these proteins and analyze the early and late consequences of their expression. We find that expression for 3 h of a polyQ-expanded protein stimulates cellular reactive oxygen species (ROS) levels and significantly reduces the mitochondrial electrochemical gradient. 24-36 h later, ROS induce DNA damage and activation of the checkpoint kinase, ATM. DNA damage signatures are reversible and persist as long as polyQ-expanded proteins are expressed. Transcription of neural and stress response genes is down-regulated in these cells. Selective inhibition of ATM or histone deacetylase rescues transcription and restores the expression of silenced genes. Eventually, after 1 week, the expression of polyQ-expanded protein also induces endoplasmic reticulum stress. As to the primary mechanism responsible for ROS generation, we find that polyQ-expanded proteins, including native Ataxin-2 and Huntingtin, are selectively sequestered in the lipid raft membrane compartment and interact with gp91, the membrane NADPH-oxidase subunit. Selective inhibition of NADPH oxidase or silencing of H-Ras signaling dissolves the aggregates and eliminates DNA damage. We suggest that targeting of the polyQ-expanded proteins to the lipid rafts activates the resident NADPH oxidase. This triggers a signal linking H-Ras, ROS, and ERK1/2 that maintains and propagates the ROS wave to the nucleus. This mechanism may represent the common pathogenetic signature of all polyQ-expanded proteins independently of the specific context or the function of the native wild type protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115499      PMCID: PMC3039353          DOI: 10.1074/jbc.M110.156521

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

3.  Histone deacetylase inhibitors reduce polyglutamine toxicity.

Authors:  A McCampbell; A A Taye; L Whitty; E Penney; J S Steffan; K H Fischbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts.

Authors:  Daniela Sarnataro; Simona Paladino; Vincenza Campana; Jacques Grassi; Lucio Nitsch; Chiara Zurzolo
Journal:  Traffic       Date:  2002-11       Impact factor: 6.215

5.  Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

Authors:  F E Rey; M E Cifuentes; A Kiarash; M T Quinn; P J Pagano
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

6.  Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.

Authors:  A Wyttenbach; J Swartz; H Kita; T Thykjaer; J Carmichael; J Bradley; R Brown; M Maxwell; A Schapira; T F Orntoft; K Kato; D C Rubinsztein
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

7.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

8.  DNA damage induced by polyglutamine-expanded proteins.

Authors:  Paola Giuliano; Tiziana De Cristofaro; Adelina Affaitati; Grazia M Pizzulo; Antonio Feliciello; Chiara Criscuolo; Giuseppe De Michele; Alessandro Filla; Enrico V Avvedimento; Stelio Varrone
Journal:  Hum Mol Genet       Date:  2003-07-22       Impact factor: 6.150

Review 9.  Wild-type huntingtin plays a role in brain development and neuronal survival.

Authors:  Anton Reiner; Ioannis Dragatsis; Scott Zeitlin; Daniel Goldowitz
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

10.  Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles.

Authors:  P Hilditch-Maguire; F Trettel; L A Passani; A Auerbach; F Persichetti; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

View more
  28 in total

1.  Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis.

Authors:  Meng Lu; Chiara Boschetti; Alan Tunnacliffe
Journal:  J Biol Chem       Date:  2015-09-25       Impact factor: 5.157

2.  RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Authors:  Núria Martín-Flores; Joan Romaní-Aumedes; Laura Rué; Mercè Canal; Phil Sanders; Marco Straccia; Nicholas D Allen; Jordi Alberch; Josep M Canals; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

Review 3.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

4.  In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production.

Authors:  Sarah Hands; Mohammad U Sajjad; Michael J Newton; Andreas Wyttenbach
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 5.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

Review 6.  Nox NADPH oxidases and the endoplasmic reticulum.

Authors:  Francisco R M Laurindo; Thaís L S Araujo; Thalita B Abrahão
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

7.  PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.

Authors:  Wei Yang; Li-Feng Yang; Zhi-Qi Song; Syed Zahid Ali Shah; Yong-Yong Cui; Chao-Si Li; Hua-Fen Zhao; Hong-Li Gao; Xiang-Mei Zhou; De-Ming Zhao
Journal:  CNS Neurosci Ther       Date:  2017-03-14       Impact factor: 5.243

8.  Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy.

Authors:  Rene L Vidal; Alicia Figueroa; Felipe A Court; Peter Thielen; Claudia Molina; Craig Wirth; Benjamin Caballero; Roberta Kiffin; Juan Segura-Aguilar; Ana Maria Cuervo; Laurie H Glimcher; Claudio Hetz
Journal:  Hum Mol Genet       Date:  2012-02-14       Impact factor: 6.150

Review 9.  Neuronal Ca(2+) dyshomeostasis in Huntington disease.

Authors:  Marta Giacomello; Juan C Oliveros; Jose R Naranjo; Ernesto Carafoli
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

10.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Patrick B Reeves; Jonathan Alexander; Kwadwo A Ansong; Nicholas Masso; Matthew P Frosch; Kimberly B Kegel; Xueyi Li; Marian DiFiglia
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.